Ignite Creation Date:
2024-05-06 @ 10:42 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03332589
Status:
TERMINATED
Last Update Posted:
2022-05-20
First Post:
2017-10-30
Brief Title:
E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases CNS
Sponsor:
Spirita Oncology LLC
Organization:
Spirita Oncology LLC
Organization Data
Organization:
Spirita Oncology LLC
Class:
INDUSTRY
Study ID:
STX-101-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Spirita Oncology LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Arizona | OTHER |